-+ 0.00%
-+ 0.00%
-+ 0.00%
Biotechnology Assets names Maguenei Pari to board, replacing John Dixon
Share
Listen to the news
Biotechnology Assets names Maguenei Pari to board, replacing John Dixon
  • Biotechnology Assets named Maguenei Pari to its board on Aug. 31, 2026, replacing John Dixon, who resigned.
  • Pari also joined the audit committee and the nominations and remuneration committee; Dixon stepped down from both.
  • Pari is a fund manager and administrator at House Hanover, the general partner of House Hanover Spain S.C.A., SICAR.
  • House Hanover Spain holds an indirect significant stake in the company via BTC Uno and BTC Diez.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biotechnology Assets SA published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending